Nomura Asset Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Nomura Asset Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$2.3K	–	1536
2023 Q4	$2.3K	Hold	100	–	–	﹤0.01%	1524
2023 Q3	$2.04K	Hold	100	–	–	﹤0.01%	1537
2023 Q2	$2.33K	Hold	100	–	–	﹤0.01%	1546
2023 Q1	$2.33K	Sell	100 -22,700	-100%	-$568K	﹤0.01%	1538
2022 Q4	$574K	Hold	22,800	–	–	﹤0.01%	859
2022 Q3	$602K	Buy	22,800 +22,700	+22,700%	+$701K	﹤0.01%	845
2022 Q2	$1.5M	Hold	100	–	–	0.01%	757
2022 Q1	$3.44K	Buy	+100	New	+$3.53K	﹤0.01%	1546
2021 Q4	–	Sell	-6,300	Closed	-$319K	–	1033
2021 Q3	$319K	Hold	6,300	–	–	﹤0.01%	893
2021 Q2	$328K	Hold	6,300	–	–	﹤0.01%	933
2021 Q1	$288K	Buy	+6,300	New	+$308K	﹤0.01%	921

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Nomura Asset Management's IDNA Position: Q1 2024 in Review

Nomura Asset Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2024, closing a stake of 100 shares — an estimated $2.3K sold.

Nomura Asset Management first reported a position in IDNA in Q1 2021 and held it in 11 quarters. The position peaked at $1.5M in Q2 2022. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Nomura Asset Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2024 after selling out during the quarter.
Nomura Asset Management sold 100 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $2.3K.
Nomura Asset Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and held it in 11 quarters.
Nomura Asset Management's iShares Genomics Immunology and Healthcare ETF position peaked at $1.5M in Q2 2022.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Nomura Asset Management's 13F filing for Q1 2024, filed 13 May 2024.